Healthcare -
Biotechnology - NASDAQ - US
$ 9.2
-0.325 %
$ 1.34 B
Market Cap
-2.62
P/E
ETNB - COST OF REVENUE
Cost of Revenue ETNB - 89bio, Inc.
273 K
LAST VALUE
85.90%
2 YEAR CAGR
114.59%
5 YEAR CAGR
0.00%
10 YEAR CAGR